Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-04-25FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application to add intravenous pantoprazole sodium (PROTONIX I.V.) as a new dosage form for the drug, expand…
-
FDA approval · 2019-04-25FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for PROTONIX DELAYED-RELEASE (pantoprazole sodium) from Wyeth Pharmaceuticals (a Pfizer subsidiary).
-
FDA approval · 2019-04-09FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Pepcid AC Maximum Strength (famotidine) by Kenvue Brands LLC.
-
FDA approval · 2019-04-04FDA Approved: PRILOSEC OTC — Supplemental Application (The Procter & Gamble Manufacturing Company)
FDA approves a supplemental application for Prilosec OTC (omeprazole magnesium) submitted by The Procter & Gamble Manufacturing Company.
-
FDA approval · 2019-04-04FDA Approved: NEXIUM 24HR CLEARMINIS — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NEXIUM 24HR CLEARMINIS (esomeprazole magnesium) filed by Haleon US Holdings LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-04-04FDA Approved: NEXIUM 24HR — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NEXIUM 24HR (esomeprazole magnesium) by Haleon US Holdings LLC, adding a 24-hour formulation to …
-
CLINICAL_TRIALS trial_result · 2019-04-01Clinical Trial Update: A Trial of C13-CAC Breath Test in PPI Resistant GERD Patients [Phase 2]
Phase 2 clinical trial update on a C13-CAC breath test for patients with PPI-resistant gastroesophageal reflux disease (GERD) has been compl…
-
FDA approval · 2019-03-26FDA Approved: TAGAMET — Supplemental Application (Prestige Brands Holdings, Inc.)
FDA approved a supplemental application for Tagamet (cimetidine) from Prestige Brands Holdings, Inc., resulting in an updated product labeli…
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Efficacy of Zinc L-carnosine in Maintaining Remission of Gastroesophageal Reflux Disease [Phase 4]
Phase 4 trial evaluating zinc L-carnosine for maintaining remission in gastroesophageal reflux disease.
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: In Vivo Anatomy, Physiology, Mechanics and Function of the Lower Esophageal Sphincter
A terminated clinical trial investigating the anatomy, physiology, mechanics, and function of the lower esophageal sphincter in relation to …
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: True Short Esophagus in Gastroesophageal Reflux Disease
The University of Bologna-sponsored clinical trial investigating true short esophagus in gastroesophageal reflux disease has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Cromolyn Detection of Silent Aspiration [Phase 1]
A Phase 1 study evaluating cromolyn for detecting silent aspiration was terminated; it addressed conditions including gastroesophageal reflu…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: High Definition Endoscopy With NBI. Contribution in Patients With Non-erosive Esophagitis
A completed clinical trial evaluating high-definition endoscopy with narrow-band imaging (NBI) in patients with non-erosive gastroesophageal…
-
CLINICAL_TRIALS trial_result · 2019-02-08Clinical Trial Update: A Placebo Controlled Trial With Baclofen for the Treatment of GERD Patients With Incomplete PPI Response [NA]
A completed placebo-controlled trial evaluated baclofen for treating gastroesophageal reflux disease in patients with incomplete response to…
-
FDA approval · 2019-02-07FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for Lannett Company's generic rabeprazole sodium product.
-
CLINICAL_TRIALS research · 2019-02-05Clinical Trial Update: A New System for GERD Diagnosis and Treatment
This update describes an ongoing clinical trial evaluating a new system for diagnosing and treating gastroesophageal reflux disease (GERD).
-
FDA approval · 2019-02-01FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for rabeprazole sodium (generic) submitted by Aurobindo Pharma Limited. This confirms an approve…
-
FDA approval · 2019-01-31FDA Approved: RANITIDINE — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved an original ANDA for ranitidine from Rising Pharma Holdings, Inc., enabling the marketing of a generic ranitidine product.
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: BRAVO Study for Functional Dyspepsia [Phase 4]
The BRAVO study, a Phase 4 clinical trial conducted by the Chinese University of Hong Kong, focusing on functional dyspepsia and gastroesoph…
-
CLINICAL_TRIALS research · 2019-01-31Clinical Trial Update: Outcomes for Patients With Gastro-Esophageal Reflux Disease
This is a clinical trial update about outcomes in patients with gastroesophageal reflux disease, sponsored by Tianjin Happy Life Technology …
-
CLINICAL_TRIALS trial_result · 2019-01-29Clinical Trial Update: Impact of Gastroesophageal Reflux and Aspiration on Airway Inflammation and Microbiome in Children With Chronic Cough
This trial update reports on a completed study examining how gastroesophageal reflux and aspiration affect airway inflammation and the airwa…
-
CLINICAL_TRIALS trial_result · 2019-01-29Clinical Trial Update: Stretta In Reflux Uncontrolled by IPP [NA]
A completed clinical trial evaluating the Stretta radiofrequency procedure for gastroesophageal reflux disease not controlled by proton pump…
-
FDA approval · 2019-01-18FDA Approved: LANSOPRAZOLE — Original Application (Medcore LLC)
The FDA approved Lansoprazole as an original generic application (ANDA) from Medcore LLC, making a generic version available.
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: A Validation Study of the Dx-pH Probe in Children for the Detection of Extra-oesophageal Reflux [NA]
This completed pediatric trial evaluated the Dx-pH Probe for detecting extra-oesophageal reflux and aimed to validate its diagnostic utility…
-
FDA approval · 2019-01-15FDA Approved: ZEGERID OTC — Supplemental Application (Riley Consumer Care LLC)
The FDA approved a supplemental application for ZEGERID OTC (omeprazole and sodium bicarbonate) submitted by Riley Consumer Care LLC.